A B S T R A C T The renal handling of' the biologically active glucagon component (the 3,500-mol wt fraction of immunoreactive glucagon [IRG]) and the contribution of the kidney to its overall peripheral metabolism were studied in normal and uremic rats. The metabolic clearance rate of glucagon was 31.8 ± 1.2 ml/min per kg in normal animals and was diminished by approximately one-third in each of three groups of rats with compromized renal ftinction:
22.3+1.6 ml/min per kg in partially (70%) nephrectomized; 22.9±3.3 ml/min per kg in bilaterally ureteral ligated; and 23.2± 1.2 ml/min per kg in bilaterally nephrectomized animals. In normal rats the kidney contributed 30% to the overall metabolic clearance of the hormone and the renal extraction of endogenous and exogenous glucagon was similar, averaging 22 .9±1.6% and was independent of plasma IRG levels over a wide range of arterial concentrations. The remnant kidney of partially (70%) nephrectomized aniimals continued to extract substantial amounts (16.6±4 .2%) of the hormone, but accounted for only 8% of the total peripheral catabolism of' IRG. In the two groups of' animals with filtering kidneys, renal glucagon uptake was linearly related to its filtered load and could be accounted for by glomerular filtration and tubuilar reabsorption. However, the kidneys of animals with both ureters ligated (renal extraction of' inulin = 3.2±1.8%) and hence virtual absence of glomiiertilar filtration, continuied to extract 11.5±1.9% of the renal arterial glucagon, contributing by 9% to its overall metabolic clearanee, indicating that IRG uptake occurs also from the post glomerular capillaries.
INTRODUCTION
Alterations in the endocrine milieu, which result in part from the inability of the diseased kidney to degrade polypeptide hormones, are prominent features of the uremic syndrome (1) . Glucagon is such a hormone, and in uremic man and animals the substantial elevations of its circulating levels and alterations in its immunoreactive composition have beeni attributed to the impaired renal degradation rather than the biochemical environment of uremia (2) (3) (4) (5) (6) (7) (8) (9) . In fact, the uremic state per se fails to cause hyperglucagonemia or changes in immunoreactive glucagon (IRG)l composition in animals with normal kidneys rendered azotemic by urine auitoinfusion. On the other hand, cessation of glomerular filtration rate (after ligation of both uireters) or bilateral nephrectomy leads to marked and quiantitatively similar increments in total plasma IRG (9) .
Compositional alterations of the circullating IRG patterns are observed only in anephric animals, in which a proglucagon-like material with a molecular weight of 9,000 constitutes more than a third of' the hormonal immunoreactivity. In contrast, the hyperglucagonemia observed after uireteral ligationi is almost entirely a restult of accutinulation of the 3,500-mol wt glucagon component, which is the biologically active fraction of' the eiretlating hornmoine (10) . These (9) . The present study was therefore undertaken in order to elucidate the disposition of the 3,500-mol wvt glucagon component by the normal rat kidney and to define the renal contribution to the overall peripheral metabolism of the hormone. In addition, the renal handling and the metabolic clearance rate of this component of IRG was studied in animals with nonfiltering kidneys and in rats in which rates of glomerular filtration, renal plasma flow, and renal mass were markedly reduced by partial (70%) nephrectomy (70% Nx).
M ETHODS Animals. All experiments were performed on male albino rats (ARS/Spraguie-Dawley Division, The Mogul Corp., Madison, Wis.) weighing 250-350 g. 24 h before the study bilateral nephrectomy, bilateral ureteral ligation (BUL), or a sham operation was performed through a midline incision under light pentobarbital anesthesia (50 mg/kg body wt i.p.). An additional group of rats, 3 wk before the experiment, underwent a partial nephrectomy (11) that resulted in ablation of 70+1% of their renal mass.2 After surgery all animals received chloramphenicol (100 mg/kg body wt i.m.) and were fasted during the 24-h preceding the study, while water was withheld only from anuric rats.
On the morning of the experiment animals were anesthetized with Inactin (Promonta, Hamburg, West Germany) 100 mg/kg body wt i.p., and the trachea, the bladder, one jugular vein, and carotid artery were cannulated. In non-nephrectomized animals the left renal vein was entered with a hooked 27-gauige neeclle segment connected to silastic tubing, which was kept patent throughouit the experiment by a constant infusion (10 ,lA/min) of heparinizecl saline (25 U/ml). This approach allowed the withdrawal of renal venouis blood utp to 3 h after catheter placement, without mclanipulatioin of the retroperitoneuim, a maneuver that in preliminarv experimiienits was shown to cause actute increments in IRG levels, making the interpretation of renal extraction data (lifficuilt. After were obtained for clearance measurements. Renal arteriovenous differences were estimated from renal venous blood collected simultaneously with the last arterial sample. All blood samples were withdrawn in chilled heparinized plastic syringes and immediately transf'erred to iced glass tubes containing Trasylol 500 U (Mobay Chemical Co., Pittsburgh, Pa.) and EDTA 1.5 mg/ml of blood. Urine was collected in chilled plastic tubes; blood samples were centrifuged at 4°C and all samples were stored at -20°C until assayed.
Evaluation of the renal handling of low arterial levels of endogenous hormone was carried out by omitting the infusion of exogenous glucagon and the renal metabolism of high endogenous IRG concentrations was investigated in normal rats during the infusion (40 plA/min) of a 25% solution of arginine hydrochloride. In these experiments, samples of urine and blood were collected 30 min after the start of the arginine infusion when maximal alpha cell stimulation and stable peripheral glucagon levels were achieved (12) .
To estimate the renal clearance of glucagon (RCIRG) in BUL rats renal blood flow and hormonal extraction rates (E)IRG were determined during glucagon infusion in seven animals which underwent 24 h previously BUL. Renal blood flow in this group was determnined by a modification of the tracer microsphere techni(lue of Hsu et al. (13) . The surgical preparation was identical to the one described above with the exception that, in addition, one femoral artery was cannulated with polyethylene-50 tubing. After blood collection for measurement of renal glucagon extraction and replacement of'blood losses with normal saline over 20 min, a suspension of -60,000 141Ce-labeled microspheres 15 ,um in diameter (3M Co., Nuclear Division, St. Paul, Minn.) in 0.1 ml of 10% dextran was injected rapidly into the carotid artery. 10 s before the injection, withdrawal of' blood was commenceed at a rate of' 0.68 ml/min and continuied for 60 s with a conitiniuous automatic infutsioni-withdrawal pump (model 600-950, Harvard Apparatuis Co., Inc., Millis, NIass.). WVhole kidney and blood radioactivity were determined in a gamma couinter (Packard Instrumiiient Co., Inc., Downers Grove, Ill.) and bloodl flow (expressed in milliliters per minute) caleculated from their ratios xO.68. Renal plasmiia flow (RPF) was estimated f'rom the product of' renal blood flow x (1-hematocrit).
Alaterials, antd assay procedures. The somatostatini (fronm Dr. K. H. Gabbay, Harvard Medical School, Boston, Mass.) infusate vas prepared in hypertonic dextrose (15 or 42%) from a stock solution containinig 1 mg of' the peptide per milliliter of isotonic salinie (pH 7.4 with Tris-HCI buff'er) and 0.2% bovine serum albumin. The glucagon inf'usate (crystalline porcine glticagon, Eli Lilly & Co., Indiancapolis, Ind.) was prepared in isotoniie saline f'rom a stock solutioni of the polypeptide (70 ,ug/nml) dissolved in glycine buffer (pH 8.8) coontainiing 1% l)ovine seruin albtmini to prevenit loss by absorption onto the glasswvare anid polyethytlenie tubing.
IRG was measured by a douible-anitibody radioi mmuiitinoassav anid gel filtration of plasmiia samples was carried out as described (6) . A specific alpha cell glucagon antibody (30K) obtained from Dr. Roger Unger, University of Texas Southwesterni Medical School, Dallas, Tex. was used. The intraassay coefficient of variation for samiiples above 80 pg/mIii in this systemil averaged 3.7±0.5% and 11.9±2.4% for samples containiing <80 pg/mil. Raclioactiye intilinl and{l PAH concelltrationis in utriine and blood wvere determinied tising a li(quid scinitillation couinter (Paickard Inistrtiuimenit Co., Inic.). Urea w as (letermili nied by a milodlification of the Berthelot mlethod (14) and glucose was mieasured by the gltucose oxiclase mlethocl (15) .
Calculations. The urinary clearance (UC) of glucagon was calculated from its urine (U): plasma concentration ratio and the urine flow: UCIRG = UIRG X urinary volume/arterialMRG. Extration (E) rates of inulin, PAH, and glucagon were calculated from their arterial (A) and renal venous (RV) concentrations: E = (A-RV)/A x 100. RPF was derived from the ratio of the clearance (C) of PAH to its renal extraction: RPF = CPAH/EPAH.
The renal clearance (RC) of glucagon was estimated from the product of its extraction rate and the RPF: RCIRG = EIRG X RPF. Renal glucagon uptake was calculated from the product of its RC and arterial hormonal concentration, while the product of the arterial IRG concentration and the glomerular filtration rate (GFR) was taken to represent the filtered load of the hormone, assuming that glucagon has a glomerular sieving coefficient of one: renal glucagon uptake = RCIRG x AIRG; filtered glucagon load = GRF X AIRG.3
Metabolic clearance rates (NICR) were measured by the constant infusion technique (17) and calculated from the ratio of the infusion rate to the steady-state plasma concentration minus the postsuppression IRG level: MCRIRG = infusion rate/ AIRG-nonsuppressible IRG. In view of the considerable adherence of IRG to glass and plastic tubing, infusion rates of the hormone were estimated at the point of entry into the animal and calculated from the IRG concentrations of timed infusate aliquots, collected after completion of the experiment from the cut end of the jugular catheter. These samples were measured in the same assay together with urine and arterial and renal venous blood specimens from each individual experiment.
Statistical methods. Results are presented as mean-+±SEM.
Regression lines were calculated by the method of least squares and the similarity of the slopes evaluated according to a standard formula (18) . The statistical significance of differences between means of each experimental group and that of controls was assessed by the Student's t test, P values <0.05 being considered significant.
RESULTS
Preliminary experinments. In preliminary experiments it was shown that the infusion of somatostatin and glucose resulted in maximal and sustained suppression of endogenous IRG levels in all four experimental groups after 45 min. Fasting IRG levels of 232 +17 pg/ml in controls (n = 36), 226±30 pg/ml in 70% Nx (n = 10), 623±64 pg/ml in BUL (n = 22), and 517 +46 pg/ml in bilateral niephrectoimv (Nx) (ni = 17) were suppressed to 67+8, 62+8, 237+34, and 267±24 pg/ml respectively. Interestingly, the degree of suppression was approximately proportional to the previously described contribution of the 3,500 mol wt component to the total plasma IRG concentration (9 (19) (20) (21) (22) .
Evaluation of IRG composition in selected post suppression plasma samples revealed that the 9,000-mol wt proglucagon-like material was largely responsible (70%) for this finding in anephric animals, while the 3,500-mol wt component persisted in measurable, albeit markedly decreased, amounts in all four experimental groups during maximal somatostatin and glucose suppression. Blood glucose levels, measured 90 min after beginning of its infusion together with somatostatin, were elevated in all groups, but were slightly higher in uremic rats: (636±6 vs. 599±14 mg/100 ml, P < 0.05). Although it is appreciated that the glucagoni infusion experiments were performed in hyperglycemic animals, the need to suppress endogenous glucagon release necessitated this approach.
Renal handling of enidogenous and exogenous glucagont in normal rats. The renal metabolism of endogenous glucagon was studied in sham-operated animals during constant infusions of somatostatin and glucose, or arginine (in = 13). The disposition of exogenou.s hormone by the kidney was investigated in identically handled rats in wNhich administration of porcine glucagon was superimposed on a somatostatin and glucose infusion (nt = 21). This approach allowed the evaluation of renal extractioni and clearance rates of IRG of both endogenous andl exogenous origin over a wide range of arterial levels (101-2170 pg/ml), glucose concentrationis, and filtered loads (834-22164 pg/min per kg body vt). In experiments in which glucagon suppression was maximal (arterial IRG: 47±5 pg/ml, range 27-63 pg/ml), the sensitivity of the assay did not allowN the accurate measurement of renal arterio-venous differences and these data were therefore excluded. The mean renal extraction (E) of IRG was 22.9± 1.6% and its average clearance was 7.5+0.6 mI/min per kg body wt. These values remained constant despite >20-fold changes in IRG arterial levels and no differences in the renal handling of glucagon of either endogenotus (EIRG= 21.0 +2.7% and RCIRG= 6.7±0.9 ml/min per kg body wt) or exogenous origin (EIRG = 24.1+1.9% and RCIRG = 7.9 +0.7 ml/min per kg body wvt) were observed (Fig. 1) .
Furthermnore, in agreement with a previous report (23) the degree of glycenmia did not appear to affect the renal mietabolism of the hormone (Fig. 1) +3.3 ml/min per kg body wt, whereas the RC of seven BUL rats studied separately averaged 2.0±0.9 m3il/min per kg body wt, suggesting that the nionifiltering kidney contributes -9% to the overall metabolic disposition of this hormone. Eachl of' the three renal ablative maneuvers depressed the metabolic clearance rate of IRG by approximatelv one-third: (70% Nx = 22.3±+1.6 ml/iiiin per kg body wt, (n = 8); BUL: 22.9±3.3 ml/min per kg body wt, (it = 9); Nx: 23.2±+1.2 ml/miiii per kg body wt, (n = 12). Partially nephrectomized rats were not hyperglucagonemic despite the decremiient in their MCR (IRG: 238±36 pg/ml vs. 191+27 pg/ml in controls), whereas bilaterally nephrectomized and ureteral-ligated rats exhibited substantial and (Itantitatively similar elevations of their fasting IRG levels (Nx: 440+36 pg/ml, BUL 405±47 pg/ml; both P < 0.001 vs. controls). anid 70% Nx rats is indicated bv the clear bars. In seven BUIL animals studied separately renal gltucagoni clearance (not shooln) averaged 2.0+(0.9 ml/min per kg body vt and thus contributed -9% to the total metabolic disposition of the peptide.
10
Emmatnouel, Jaspaii, Rubenstebin, lIien, Fitnk, and Katz r% r) EEL of this hormone. Kidney tissue contains specific glucagon-degrading enzymes in both the proximal tubular cytosol and brush border (25, 26) . Glucagoin is taken tip avidly by the autotransplanted as well as by the in vitro perfiused kidney of the dog (23, 27) and by the rat kidney in situ (28) . In animals, bilateral nephrectomy, uireteral ligation, or renal pediele-clamping lead promptly to hyperglucagoniemia (3, 8, 9, 22, 29, 30) . In patients with renal failture basal glucagon levels are substantially elevated (2) (3) (4) (5) (6) (7) (8) and the NICR of exogenously adiministered hormone is markedly decreased (5). NMost of the above mentioned studies did not take into account the heterogeneity' of circulating IRG and the alterations in its compositioni which occur in renal insufficiency (6, 8, 9) . Because the various immunoreactive components of the hormone are probably handled by different renal mechainism-ls (9), the present investigation was focused on the renal handling and the contribuition of' the kidney to the overall peripheral metabolism of the biologically active component of glucagon (the 3,500-mol wt fractioin) (10) . The renal han-(Iling and the MCR of this material was evaluated during a constant infusion of crystalline porcine glucagon (3,500 mol wt) superimposed on the administration of sonmatostatini and glucose, which in preliminary studies was shown to produce a sustainied suppression of endogenous hormonal levels in all experimental groups of animals. Our results thus describe the renal and the ov-erall peripheral dispositioni of3,500 mol wvt glucagoni, that was studied in normal, as wvell as in partially nephrectomized, ureteral ligated, and bilaterally nephrectomized rats. Furthermore, studies conducted in normal rats infused with maxim-lally effective stimulating doses of arginine demonstrate that the renal handling of the endogenous 3,500 mol wt component of the rat is not different from that of the porcine hormone.
The renal handling of the 3,500-mol wvt glucagon vas studied over a wide ranige of arterial concentrations thus simnulating filtered hormonal loads encountered in a variety of physiologic and pathologic states. In normal rats the arteriovenous IRG concentration difference averaged 22.9± 1.6%, a value quite siimiilar to that found in the dog (25%) by Lefebvre et al. (23, 27) , but loxwer than the one described by Bastl et al. (28) in rats (39%). In the latter study though, endogenous IRG release was not suippressed and renal vein canniulation imi-meidiately preceded blood collection for measurement of arterio-venous differences, this approach in our experience, causes substantial increments in plasma glucagoni levels and acute changes in renial hemodynamics, making extraction data difficult to interpret. Despite marked reduction in the GFR and RPF, the remnanit kidney' of partially nephrectomized rats continued to extract substantial amounts (16.6+4.2%) of glucagon-from the circulation, a finding, which is also at variance with the resuilts of Bastl et al. (28) . In our study the decrement in the RC of the peptide in these animals couild be attributed to the reduced filtration rate and the resulting decrease in the filtered load of the hormone. The renal parenchyma of both control and 70% Nx rats catabolized virtually all of the extracted peptide, since in both groups urinary glucagoni excretion was negligible, representing <0.3% of the overall renal hormonal clearance,5 an estimate comparable to that reported for insulin (0.2%) in the rat (31) . In both groups the renal uptake ofthe hormone was linearly related to its filtered load (controls: y =0.70x + 0.87, r = 0.82, P < 0.001; 70% nephrectomiiized: y = 1.15x -0.25, r = 0.72, P < 0.05) and the slopes of these linear regressions did not differ, suggesting that at e(quivalent IRG-filtered loads both groups extracted and catabolized similar amounts of the hormone. Furthermore, evaluation by column fractionation of the IRG measured in arterial and renial venous samples showed similar immunological patterns in the two groups, indicating that the 3,500-mol wt glucagon componenit is handled siinilarly by the normal and by the remnanit kidney (Fig. 3) .
In these two groups of animials glucagon extraction was not significantly different from that of inulin. In 70% Nx rats inulin and glucagon-clearances were comparable, while in sham-operated rats the clearance of the hormonie was only slightly lower than the GFR. Althouigh these results could be interpreted as indicating that renal glucagon extraction, in animals with filtering kidneys, can be accounted for by glomerular filtration and tubular reabsorption, it is likely that uptake from postglonmerular capillaries, as postuilated for insulin (31) , also occurs. In fact, animals with both ureters ligated, maintainied renal perftusion and barely measurable extraction of inulini conitinuied to extract 11.5% of the renal arterial glucagon, indicating that peritubular glucagoni uptake occurs, at least in the nonfilterinig kidney. This might also be the case for the 9,000-mol wt proglucagoni-like material, wvhich accumulates only after bilateral nephrectomy but not after BUL (9) .
In agreement with reports stressing the prominent role of' nonrenal degrading sites, suiclh as the liver, in the overall peripheral disposition of the 3,500-mol wNt glucagon comiiponent (32) the kidney contributed in normal animnals only 30% to its MCR. All three renal ablative maneuvers used in the present study depressed the metabolic clearance of IRG also by -30% anid in BUL and 70% Nx rats this decrement could 5Urinary clearances of both insulin and gluicagon are suLbstantially higher in the dog (4.7 and 4.1% of their respective RC) suggesting that the renal tubular han(dlinig of these peptides is different in this species (23) .
be accounted for almost entirely by the impaired renal clearance of the hormone. Whereas, bilaterally nephrectomized and ureteral-ligated rats exhibited substantial and quantitatively similar elevations of their basal IRG levels, partially nephrectomized rats were not hyperglucagonemic despite their comparably decreased MCR. Because chronic starvation markedly depresses both the secretory and MCR of IRG (33) , this factor might account at least in part for our results in the partially nephrectomized rats.
In summary, this study has demonstrated that the normal rat kidney extracts and catabolizes 23% of the 3,500-mol wt glucagon component, independent of its arterial concentration, and that this organ contributes 30% to the overall metabolic disposition of glucagon. The remnant renal parenchyma of 70% Nx rats, while contributing <8% to the total peripheral metabolism of this component of glucagon, continues to extract and catabolize substantial amounts of the hormone in a manner similar to that of the normal kidney. Althouigh glucagon uiptake by the filtering kidniey could be accounted for by glomerular filtration and tubular reabsorption, this mechanism is not solely responsible for renal IRG handling. In fact, animals in which GFR has virtually ceased continue to extract substantial amounts of the hormone, indicating that peritubular entry from postglomerular capillaries also occurs and actuially is the predominant mode of IRG uiptake by the nonfiltering kidney.
